TD Asset Management Inc Sells 12768 Shares of DaVita
December 2, 2023
☀️Trending News
DAVITA ($NYSE:DVA): It operates kidney dialysis centers and provides services to patients with chronic kidney disease and end stage renal disease. The company also provides clinical research, health insurance services, and other related services. The company’s stock value has been increasing steadily over the past few years, becoming one of the top performing healthcare stocks on the market. DaVita Inc. is well-positioned to continue to provide quality care to its patients, while providing a solid return for its shareholders.
Price History
The stock sale was a part of an institutional sale which was reported to the SEC. Despite the minimal increase, DaVita Inc. continues to be a strong stock for investors in the healthcare sector. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Davita Inc. More…
| Total Revenues | Net Income | Net Margin |
| 11.91k | 608.97 | 5.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Davita Inc. More…
| Operations | Investing | Financing |
| 1.92k | -816.77 | -998.15 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Davita Inc. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 16.93k | 14.1k | 13.13 |
Key Ratios Snapshot
Some of the financial key ratios for Davita Inc are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 1.0% | -6.4% | 12.1% |
| FCF Margin | ROE | ROA |
| 11.0% | 81.1% | 5.3% |
Analysis
At GoodWhale, we have conducted an analysis of DAVITA INC‘s financials. According to our Star Chart, DAVITA INC has a high health score of 8/10, indicating that it is in good financial shape with its cashflows and debt. It is also capable of paying off debt and funding operations in the future. Furthermore, DAVITA INC is strong in profitability, but weak in asset, dividend, and growth. On the basis of this analysis, we have classified DAVITA INC as a ‘sloth’, meaning that it has achieved revenue or earnings growth slower than the overall economy. Given DAVITA INC’s current financials, we believe that value investors who are looking for companies with stable cashflows and debt may be interested in investing in the company. Additionally, investors looking for long-term growth opportunities may find DAVITA INC to be a sound choice. More…
Peers
In the dialysis industry, DaVita Inc. competes with Acadia Healthcare Co Inc, Fresenius Medical Care AG & Co. KGaA, Medical Facilities Corp, and other companies. The company has a network of 2,664 outpatient dialysis centers in the United States that serve approximately 198,000 patients with end-stage renal disease.
– Acadia Healthcare Co Inc ($NASDAQ:ACHC)
Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. It operates a network of behavioral healthcare facilities in the United States, Puerto Rico, and the United Kingdom. The company offers inpatient psychiatric and substance abuse services, residential treatment, outpatient behavioral health services, and specialty behavioral healthcare services.
– Fresenius Medical Care AG & Co. KGaA ($LTS:0H9X)
Fresenius Medical Care AG & Co. KGaA, a renal care company, provides products and services for patients with renal diseases worldwide. The company’s products and services include dialysis machines, dialyzers, and related disposable products, as well as renal pharmaceuticals. It also offers clinical laboratory testing services. The company was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
– Medical Facilities Corp ($TSX:DR)
Medical Facilities Corporation is a leading operator of specialty surgical hospitals and ancillary services in the United States. The company owns and operates seven specialty surgical hospitals, one surgical hospital, and three surgical facilities located in Arkansas, Illinois, Louisiana, Mississippi, Oklahoma, and Texas. Medical Facilities Corporation’s hospitals offer a broad range of services, including general surgery, cardiovascular surgery, orthopedic surgery, pain management, gastroenterology, urology, and otolaryngology. The company’s hospitals are accredited by the Joint Commission on Accreditation of Healthcare Organizations and are licensed by the respective state Departments of Health.
Summary
Analysis of various financial metrics, including revenue growth, book value per share, and operating cash flow suggest that DaVita remains a financially strong company.
Related Posts
Recent Posts
